Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Gilead Sciences to Buy Ouro Medicines for $1.68 Billion Upfront
Gilead Sciences has plans to acquire Ouro Medicines based in South San Francisco, California. The transaction, which was announced on March 24, includes an upfront payment of approximately $1.68 billion, along with up to $500 million in milestone-based payments linked to development and regulatory progress. Ouro Medicines is a privately held biotechnology company. Ouro’s lead investigational antibody therapy, OM336, is currently in early-stage development for autoimmune conditions, including hemolytic anemia and Sjogren’s disease. Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. Gilead has... Read More »
The Money Always Wins: A Healthcare Webinar Wrap Up
Last week, Ben Swett, Managing Editor of The SeniorCare Investor, was joined by John Tiedmann, Managing Director at Physician Growth Partners, Bill Hoffman, Shareholder at Polsinelli and Matt Bogle, Managing Director at Intrinsic, to discuss the trends facing the healthcare industry. Based on data in the LevinPro HC database, the conversation covered a wide range of topics, from the post-2022 decline in deal volume to the specific specialties currently attracting the most investor interest. Although 2025’s deal total in the healthcare services sectors (1,793) marks a steady climb from 2024 (1,676), it still trails the heightened activity seen in 2022 (2,028) and 2021 (1,880). The panel... Read More »
Retina Consultants of America Announces $1.1 Billion Acquisition
On March 23, Cencora announced that its portfolio company, Retina Consultants of America (RCA), entered into an agreement to acquire EyeSouth Partners’ retina business. The purchase price is $1.1 billion, marking the largest eye care purchase price in the last five years and the largest Physician Medical Group (PMG) deal of 2026 so far. Based in Atlanta, Georgia, EyeSouth Partners, a portfolio company of Olympus Partners as of 2022, is an eye care services organization.EyeSouth’s affiliate network comprises more than 400 doctors providing medical and surgical eye care at more than 275 locations across 14 states. Additionally, it operates 26 surgery centers throughout 12 states. RCA... Read More »
Momentum Health Partners Launches with Purchase of AACT
Phoenix, Arizona-based Momentum Health Partners has announced its official launch alongside the acquisition of Advanced Autism Center for Treatment (AACT) of Gilbert, Arizona. AACT is a provider of autism and developmental therapy services. The company offers center- and home-based autism programs, along with complementary therapy and respite services. Momentum Health Partners is a healthcare-focused private equity platform backed by MCR Companies, a fully integrated real estate and private equity investment firm. The firm focuses on lower middle-market healthcare services businesses and pursues majority partnerships with providers delivering community-based care. With the acquisition of... Read More »
Oasis Health Partners Picks Up Premier Health
Oasis Health Partners announced its first acquisition of 2026 with the purchase of Premier Health. Financial terms were not disclosed. Premier Health is a healthcare administrative services organization specializing in revenue cycle management (RCM) and practice operations. Oasis Health Partners is a value-based healthcare organization focused on building healthier communities by advancing primary care. It is based in Columbia, South Carolina. This acquisition builds upon Oasis’s continued expansion, including its recent growth into North Carolina through the October 2025 acquisition of PreferCare. “We’re proud to join Oasis at such an exciting time,” said Robert Downing, Chief Financial... Read More »LevinPro HC Stat of the Week: Physician Medical Group M&A by Specialty
In our LevinPro HC Stat of the Week, we’re looking at the breakdown of Physician Medical Group M&A and which specialties have been a priority for investors in 2026. Dental groups remain popular targets for investors this year, accounting for 45% of year-to-date deal volume, with 53 transactions. Internal medicine, dermatology, and orthopaedic practices have also received some attention in the healthcare M&A market. The buyers behind the deals reveal some key market trends. Dental groups are the primary targets for private equity-backed firms, such as MB2 Dental Solutions and U.S. Oral Surgery Management, but internal medicine and orthopaedic groups are more likely to be... Read More »
Michigan ENT & Allergy Specialists and Grand Rapids Ear, Nose & Throat Merge
Michigan ENT & Allergy Specialists and Grand Rapids Ear, Nose & Throat have announced a merger. Terms were not disclosed. Grand Rapids Ear, Nose & Throat is an ear, nose & throat (ENT) practice with one location in Grand Rapids, Michigan. There are six physicians on staff. Part of Parallel ENT & Allergy (a Trinity Hunt Partners portfolio company), Michigan ENT & Allergy Specialists provides otolaryngology care for all ages across the Grand Rapids, Michigan MSA. As part of complete ENT care, the practice also offers sinus and rhinology care, treatment for balance and dizziness disorders and comprehensive audiology... Read More »
Freedom Home Care Joins the PurposeCare Family of Companies
Freedom Home Care is joining the PurposeCare family of companies, according to a March 17 press release. Freedom Home Care is a home care organization serving communities throughout Cook, DuPage, Lake, Kane, Kendall and McHenry counties. The team operates out of four offices in Northern Illinois: Highland Park, Lake Forest, Barrington and Vernon Hills. Established in December 2021, PurposeCare provides home-based care to more than 3,000 clients each month. PurposeCare is a portfolio company of Lorient Capital, a private investment firm focused exclusively on the healthcare industry. As part of... Read More »
